Rectal dialysate and fecal concentrations of neutrophil gelatinase- associated lipocalin, interleukin-8, and tumor necrosis factor-α in ulcerative colitis

American Journal of Gastroenterology

Volumn 94, Issue 10, 1999, Pages 2923-2928

  Nielsen, Ole Haagen ^a   Gionchetti, Paolo ^b   Ainsworth, Mark ^a   Vainer, Ben ^a   Campieri, Massimo ^b   Borregaard, Niels ^c   Kjeldsen, Lars ^c  

^a Department of Medicine CF   (Denmark)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c FINSEN LABORATORY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE; INTERLEUKIN 8; LIPOCALIN; MESALAZINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CYTOKINE RELEASE; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; FECES ANALYSIS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; ULCERATIVE COLITIS;

ACUTE-PHASE PROTEINS; ADULT; AGED; BIOLOGICAL MARKERS; CARRIER PROTEINS; COLITIS, ULCERATIVE; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; NEUTROPHILS; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS; RECTUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032870150     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00495-5     Document Type: Article

References (34)

1. Fiocchi C., Collins S.M., James S.P., et al. "Immune/non-immune cell interactions in intestinal inflammation" workshop. Inflam Bowel Dis. 3:1997;133-141.
2. Kjeldsen L., Johnsen A.H., Sengeløv H., et al. Isolation of primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 268:1993;10425-10432.
3. Kjeldsen L., Bainton D.F., Sengeløv H., et al. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood. 83:1994;799-807.
4. Peitsch M.C., Boguski M.S. The first lipocalin with enzymatic activity. TIPS. 16:1991;363.
5. Meheus L.A., Fransen L.M., Raymackers J.G., et al. Identification by microsequencing of lipopolysaccharide-induced proteins secreted by mouse macrophages. J Immunol. 151:1993;1535-1547.
6. Quansheng L., Ryon J., Nilsen-Hamilton M. Uterocalin A mouse acute phase protein expressed in the uterus around birth . Mol Reprod Devel. 46:1997;507-514.
7. Stenson W.F., Mehta J., Spilberg I. Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (fMLP) to its receptor on human neutrophils. Biochem Pharmacol. 33:1984;407-412.
8. Gebbers J.-O., Otto H.F. Immunohistochemical and electronmicroscopic observations on the local response in ulcerative colitis. Virchows Arch (Pathol Anat). 374:1977;271-273.
9. Nielsen B.S., Borregaard N., Bundgaard J.R., et al. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut. 38:1996;414-420.
10. Kjeldsen J., Schaffalitzky de Muckadell O.B. Assessment of disease severity and activity in inflammatory bowel disease. Scand J Gastroenterol. 28:1993;1-9.
11. Baert F.J., D'Haens G.R., Peeters M., et al. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology. 116:1999;22-28.
12. Braegger C.P., Nicholls S., Murch S.H., et al. Tumour necrosis factor in stool as a marker of intestinal inflammation. Lancet. 339:1992;89-91.
13. Nielsen O.H., Rüdiger N., Gaustadnes M., et al. Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease. Scand J Gastroenterol. 32:1997;1028-1034.
14. Gionchetti P., Campieri M., Ferretti M., et al. Rilascio intracolico di interleuchina 6 (IL-6) ed interleuchina 8 (IL-8) in pazienti con colite ulcerosa. D'Albasio G., Ficari F. Atti Congresso Nazionale delle Malattie Digestive. 1994;195-198 Scientific Press, Firenze.
15. Sugi K., Saitoh O., Hirata I., et al. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease Comparison with other neutrophil-derived proteins . Am J Gastroenterol. 91:1997;927-934.
16. Langholz E., Munkholm P., Nielsen O.H., et al. Incidence and prevalence of ulcerative colitis in the county of Copenhagen 1962 to 1987. Scand J Gastroenterol. 26:1991;1247-1256.
17. Munkholm P., Langholz E., Nielsen O.H., et al. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-1987 A sixfold increase in incidence . Scand J Gastroenterol. 27:1992;609-614.
18. Tvede M., Bondesen S., Nielsen O.H., et al. Serum antibodies to Bacteroides species in chronic inflammatory bowel disease. Scand J Gastroenterol. 18:1983;783-789.
19. Binder V. A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis. Scand J Gastroenterol. 5:1970;627-632.
20. Kjeldsen L., Koch C., Arnljots K., et al. Characterization of two ELISAs for NGAL, a newly described lipocalin in human neutrophils. J Immunol Meth. 198:1996;155-164.
21. Nielsen O.H., Brynskov J., Bendtzen K. Circulating and mucosal concentrations of tumour necrosis factor and inhibitor(s) in chronic inflammatory bowel disease. Dan Med Bull. 40:1993;247-249.
22. Jewell D.P. Ulcerative colitis. Feldman M., Scharschmidt B.F., Sleisenger M.H. Gastrointestinal and Liver Disease. 6th edition. 1998;1735-1761 WB Saunders, Philadelphia.
23. 1-acid glycoprotein in chronic ulcerative colitis. Gastroenterology. 56:1969;295-303.
24. Jensen K.B., Jarnum S., Kouhdal G., et al. Serum orosomucoid in ulcerative colitis. Its relation to clinical activity, protein loss and turnover of albumin and IgG. Scand J Gastroenterol. 11:1976;177-193.
25. Targan S.R., Hanauer S.B., van Deventer S.J.H., et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. N Engl J Med. 337:1997;1029-1035.
26. Hommes D.W., Radema S.A., Jansen J., et al. Production and cellular source of interleukin-8 in ulcerative colitis. Inflam Bowel Dis. 1:1995;108-116.
27. Casellas F., Papo M., Guarmer F., et al. Intraluminal colonic release of immunoreactive tumour necrosis factor in chronic ulcerative colitis. Clin Sci. 87:1994;453-458.
28. Trautwein C., Böker K., Manns M.O. Hepatocyte and immune system Acute phase reaction as a contribution to early defence mechanisms . Gut. 35:1994;1163-1166.
29. Adeyemi E.O., Hodgson H.J.F. Faecal elastase in inflammatory bowel disease. Gut. 29:1988;A1474.
30. 1-acid glycoprotein and serum retinol-binding protein and its relatives. FASEB J. 1:1987;209-214.
31. Lollike K., Kjeldsen L., Sengeløv H., et al. Purification of lysozyme from human neutrophils, and development of an ELISA for quantification in cells and plasma. Leukemia. 9:1995;206-209.
32. Adeyemi E.O., Hodgson H.J.F. Lactoferrin A correlate of disease activity in inflammatory bowel disease . Eur J Gastroenterol Hepatol. 3:1991;51-56.
33. Sengeløv H., Boulay F., Kjeldsen L., et al. Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils. Biochem J. 229:1994;473-479.
34. Nielsen O.H., Vainer B., Bregenholt S., et al. Inflammatory bowel disease Potential therapeutic strategies . Cyt Cell Mol Ther. 3:1997;267-281.